JASPER THERAPEUTICS INC's ticker is and the CUSIP is 471871103. A total of 42 filers reported holding JASPER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $546,615 | +24.1% | 780,879 | +142.8% | 0.00% | – |
| Q2 2023 | $440,524 | -35.6% | 321,550 | -15.0% | 0.00% | – |
| Q1 2023 | $684,310 | +46356.9% | 378,072 | +12295.8% | 0.00% | – |
| Q4 2022 | $1,473 | -26.4% | 3,050 | -2.4% | 0.00% | – |
| Q3 2022 | $2,000 | -66.7% | 3,125 | +4.2% | 0.00% | – |
| Q2 2022 | $6,000 | -60.0% | 3,000 | -29.8% | 0.00% | – |
| Q1 2022 | $15,000 | -99.4% | 4,276 | -98.6% | 0.00% | – |
| Q4 2021 | $2,345,000 | +109.9% | 298,789 | +174.5% | 0.00% | – |
| Q3 2021 | $1,117,000 | – | 108,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 5,852,982 | $20,778,000 | 19.52% |
| Velan Capital Investment Management LP | 3,219,036 | $10,180,000 | 9.45% |
| Abingworth LLP | 5,628,558 | $19,531,000 | 5.54% |
| SECTORAL ASSET MANAGEMENT INC | 675,000 | $2,396,000 | 0.42% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 540,000 | $1,917,000 | 0.20% |
| Vahanian & Associates Financial Planning Inc. | 10,000 | $36,000 | 0.08% |
| Forefront Analytics, LLC | 32,550 | $118,000 | 0.04% |
| Citadel Advisors | 2,994,580 | $10,631,000 | 0.00% |
| FEDERATED HERMES, INC. | 251,697 | $894,000 | 0.00% |
| Ionic Capital Management LLC | 100 | $0 | 0.00% |